Kazia Therapeutics
KZIA
8 hedge funds and large institutions have $170K invested in Kazia Therapeutics in 2014 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 0 closing their positions.
431% more capital invested
Capital invested by funds: $32K → $170K (+$138K)
60% more funds holding
Funds holding: 5 → 8 (+3)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$141K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$36.7K |
| 3 |
Citigroup
New York
|
+$3.47K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4.46K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| $118K | +$141K | +285 | New |
|
|
VKH
2
Virtu KCG Holdings
New York
| $31K | +$36.7K | +74 | New |
|
3
Bank of America
Charlotte,
North Carolina
| $10K | – | – | – |
|
4
Morgan Stanley
New York
| $5K | – | – | – |
|
|
5
Citigroup
New York
| $3K | +$3.47K | +7 | New |
|
6
UBS Group
Zurich,
Switzerland
| $2K | +$2.98K | +6 | New |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $1K | -$4.46K | -9 | -82% |
|
KZIA Hedge Fund Activity: Q4 2014 in Review
8 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in Kazia Therapeutics (KZIA) for Q4 2014, worth a combined $170K — up 431% from $32K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new KZIA positions and 0 closed out — a net gain of 4 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $141K. The largest seller was Tower Research Capital (TRC), cutting an estimated $4.46K.
- 8 institutional investors held Kazia Therapeutics (KZIA) as of Q4 2014, up from 5 in Q3 2014.
- Funds reported $170K of Kazia Therapeutics stock for Q4 2014, up 431% quarter-over-quarter.
- 4 funds opened new Kazia Therapeutics positions in Q4 2014 and 0 closed out, a net change of +4 holders.
- The largest Kazia Therapeutics buyer in Q4 2014 was Jane Street, an estimated $141K added.
- The largest Kazia Therapeutics seller in Q4 2014 was Tower Research Capital (TRC), an estimated $4.46K sold.
Based on aggregated 13F filings for Q4 2014.